Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 262

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 16
Chunk 262
---
2025, the Company entered into a Strategic Collaboration Agreement (Collaboration Agreement) with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (Yuwell). The collaboration with Yuwell is expected to broaden the Company’s product portfolio through distribution of certain respiratory products in the United States and select other territories, expand and enhance Inogen’s innovation pipeline through R&D collaboration, and accelerate the entry of the Company’s brand into the Chinese market. The Collaboration Agreement will establish guidelines and principles relating to the parties’ cooperation with respect to distribution, research and development, licensing, and supply chain optimization. The parties have also entered into two distribution arrangements whereby Inogen will distribute certain products supplied by Yuwell in the United States and specified European countries and Yuwell will distribute certain products supplied by the Company in specified Asia Pacific countries.   Securities Purchase Agreement On January 25, 2025, the Company entered into a Securities Purchase Agreement (Purchase Agreement) with Yuwell (Hong Kong) Holdings Limited (Investor), a wholly-owned subsidiary of Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., pursuant to which the Investor purchased 2,626,425 shares  of the Company’s common stock, at a price per share of $10.36, for an aggregate purchase price of approximately $27,210 (the Private Placement). The closing of the Private Placement took place on February 21, 2025.

 F-35

Schedule II: Valuation and Qualifying Accounts

      Balance at

      Beginning

      Balance at

      of Year

      Additions

      Deletions

      End of Year

      Year ended December 31, 2024

      Allowance for doubtful accounts (1)
       
      $
      2,341

      $
      2,101

      $
      3,984

      $
      458

      Allowance for sales returns (2)

      479

      8,789

      8,855

      413

      Allowance for rental asset loss (3)

      2,606

      4,082

      2,944

      3,744

      Year ended December 31, 2023

      Allowance for doubtful accounts (1)
       
      $
      77

      $
      2,273

      $
      9

      $
      2,341

      Allowance for sales returns (2)

      483